177 related articles for article (PubMed ID: 38542527)
21. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms.
Shan L; Yu XC; Liu Z; Hu Y; Sturgis LT; Miranda ML; Liu Q
J Biol Chem; 2009 Jan; 284(3):1419-24. PubMed ID: 19028676
[TBL] [Abstract][Full Text] [Related]
22. Structural basis of endothelial lipase tropism for HDL.
Broedl UC; Jin W; Fuki IV; Glick JM; Rader DJ
FASEB J; 2004 Dec; 18(15):1891-3. PubMed ID: 15456739
[TBL] [Abstract][Full Text] [Related]
23. Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis.
Wang Q; Oliver-Williams C; Raitakari OT; Viikari J; Lehtimäki T; Kähönen M; Järvelin MR; Salomaa V; Perola M; Danesh J; Kettunen J; Butterworth AS; Holmes MV; Ala-Korpela M
Eur Heart J; 2021 Mar; 42(12):1160-1169. PubMed ID: 33351885
[TBL] [Abstract][Full Text] [Related]
24. ANGPTL3 is a novel HDL component that regulates HDL function.
Yang L; Wang Y; Xu Y; Li K; Yin R; Zhang L; Wang D; Wei L; Lang J; Cheng Y; Wang L; Ke J; Zhao D
J Transl Med; 2024 Mar; 22(1):263. PubMed ID: 38462608
[TBL] [Abstract][Full Text] [Related]
25. Undaria pinnatifida soluble fiber regulates Angptl3-LPL pathway to lessen hyperlipidemia in mice.
Xiao HB; Lu XY; Zhang HB; Sun ZL; Fang J
J Physiol Biochem; 2013 Dec; 69(4):719-25. PubMed ID: 23595961
[TBL] [Abstract][Full Text] [Related]
26. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4.
Sonnenburg WK; Yu D; Lee EC; Xiong W; Gololobov G; Key B; Gay J; Wilganowski N; Hu Y; Zhao S; Schneider M; Ding ZM; Zambrowicz BP; Landes G; Powell DR; Desai U
J Lipid Res; 2009 Dec; 50(12):2421-9. PubMed ID: 19542565
[TBL] [Abstract][Full Text] [Related]
27. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids.
Robciuc MR; Maranghi M; Lahikainen A; Rader D; Bensadoun A; Öörni K; Metso J; Minicocci I; Ciociola E; Ceci F; Montali A; Arca M; Ehnholm C; Jauhiainen M
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1706-13. PubMed ID: 23661675
[TBL] [Abstract][Full Text] [Related]
28. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.
Kovrov O; Kristensen KK; Larsson E; Ploug M; Olivecrona G
J Lipid Res; 2019 Apr; 60(4):783-793. PubMed ID: 30686789
[TBL] [Abstract][Full Text] [Related]
29. Endothelial lipase variant T111I does not alter inhibition by angiopoietin-like proteins.
Sylvers-Davie KL; Bierstedt KC; Schnieders MJ; Davies BSJ
Sci Rep; 2024 Feb; 14(1):4246. PubMed ID: 38379026
[TBL] [Abstract][Full Text] [Related]
30. The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage.
Jin N; Matter WF; Michael LF; Qian Y; Gheyi T; Cano L; Perez C; Lafuente C; Broughton HB; Espada A
ACS Chem Biol; 2021 Mar; 16(3):457-462. PubMed ID: 33656326
[TBL] [Abstract][Full Text] [Related]
31. Angiopoietin-like proteins and postprandial partitioning of fatty acids.
DiDonna NM; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2022 Feb; 33(1):39-46. PubMed ID: 34789669
[TBL] [Abstract][Full Text] [Related]
32. Angiopoietin-like 3: An important protein in regulating lipoprotein levels.
Burks KH; Basu D; Goldberg IJ; Stitziel NO
Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101688. PubMed ID: 35999139
[TBL] [Abstract][Full Text] [Related]
33. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues.
Zhang R; Zhang K
Prog Lipid Res; 2022 Jan; 85():101140. PubMed ID: 34793860
[TBL] [Abstract][Full Text] [Related]
34. The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells.
Chen PY; Chao TY; Hsu HJ; Wang CY; Lin CY; Gao WY; Wu MJ; Yen JH
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576019
[TBL] [Abstract][Full Text] [Related]
35. A unified model for regulating lipoprotein lipase activity.
Zhang R; Zhang K
Trends Endocrinol Metab; 2024 Jun; 35(6):490-504. PubMed ID: 38521668
[TBL] [Abstract][Full Text] [Related]
36. ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice.
Xiao HB; Wang JY; Sun ZL
Exp Mol Pathol; 2017 Dec; 103(3):242-248. PubMed ID: 29104012
[TBL] [Abstract][Full Text] [Related]
37. ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis.
Mohamed F; Mansfield BS; Raal FJ
Curr Atheroscler Rep; 2022 Dec; 24(12):959-967. PubMed ID: 36367663
[TBL] [Abstract][Full Text] [Related]
38. Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance.
Adam RC; Mintah IJ; Alexa-Braun CA; Shihanian LM; Lee JS; Banerjee P; Hamon SC; Kim HI; Cohen JC; Hobbs HH; Van Hout C; Gromada J; Murphy AJ; Yancopoulos GD; Sleeman MW; Gusarova V
J Lipid Res; 2020 Sep; 61(9):1271-1286. PubMed ID: 32646941
[TBL] [Abstract][Full Text] [Related]
39. Hepatic proprotein convertases modulate HDL metabolism.
Jin W; Wang X; Millar JS; Quertermous T; Rothblat GH; Glick JM; Rader DJ
Cell Metab; 2007 Aug; 6(2):129-36. PubMed ID: 17681148
[TBL] [Abstract][Full Text] [Related]
40. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.
Chen YQ; Yang Y; Zhen EY; Beyer TP; Li H; Wen Y; Ehsani M; Jackson N; Xie K; Jung H; Scheithauer JL; Kumari A; Birrane G; Russell AM; Balasubramaniam D; Liao Z; Siegel RW; Qian Y; Ploug M; Young SG; Konrad RJ
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2322332121. PubMed ID: 38625948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
